Loading company…
Morphoceuticals develops treatments based on bioelectric signaling and tissue regeneration.
Morphoceuticals uses bioelectric signaling and electroceuticals research to develop potential treatments for complex health conditions. Its work includes research into tissue and organ regeneration and channelopathies. Founded in 2022, the company is based in Boston, US. In January 2023, it raised USD 9.8 million in seed funding co-led by Prime Movers Lab and Juvenescence Limited.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in